Skip to main content
NIH funding notice RFA-MH-19-210

Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional)

Closed on December 5, 2018.

Posted
October 3, 2018
Close date
December 5, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $398,981 in first-year total cost, median $398,981.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-B (04)]1

Most frequent institutions

  1. RUTGERS, THE STATE UNIV OF N.J.1
Competing awards under RFA-MH-19-210 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Influence of Daily Disruptions in Sleep and Self-Regulation on Proximal Risk for Suicide.1RF1MH120840-01CAIN, NICOLE MLEWIS, KATIEMEEHAN, KEVIN B.RUTGERS, THE STATE UNIV OF N.J., NJ$398,981ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MH-19-210: Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional) | ScienceDex | ConductScience